References
- Abraham JA, Damm D, Bajardi A, et al. (1993). Heparin-binding EGF-like growth factor: characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem Biophys Res Commun 190:125–133
- Acharya AN, Coates H, Tavora-Vieira D, Rajan GP. (2015). A pilot study investigating basic fibroblast growth factor for the repair of chronic tympanic membrane perforations in pediatric patients. Int J Pediatr Otorhinolaryngol 79:332–335
- Burwen SJ, Barker ME, Goldman IS, Jones AL. (1985). The effect of concentration on hepatic transport of exogenous epidermal growth factor. Hepatology 5:211–214
- Coowanitwong I, Keay SK, Natarajan K, et al. (2008). Toxicokinetic study of recombinant human heparin-binding epidermal growth factor-like growth factor (rhHB-EGF) in female Sprague Dawley rats. Pharm Res 25:542–550
- Dunn WA, Hubbard AL. (1984). Receptor-mediated endocytosis of epidermal growth factor by hepatocytes in the perfused rat liver: ligand and receptor dynamics. J Cell Biol 98:2148–2159
- Dvorak DW, Abbas G, Ali T, et al. (1995). Repair of chronic tympanic membrane perforations with long-term epidermal growth factor. Laryngoscope 105:1300–1304
- Feng J, Mehta VB, El-Assal ON, et al. (2006). Tissue distribution and plasma clearance of heparin-binding EGF-like growth factor (HB-EGF) in adult and newborn rats. Peptides 27:1589–1596
- Hakuba N, Iwanaga M, Tanaka S, et al. (2010). Basic fibroblast growth factor combined with atelocollagen for closing chronic tympanic membrane perforations in 87 patients. Otol Neurotol 31:118–121
- Hakuba N, Tabata Y, Hato N, et al. (2014). Gelatin hydrogel with basic fibroblast growth factor for tympanic membrane regeneration. Otol Neurotol 35:540–544
- Hakuba N, Taniguchi M, Shimizu Y, et al. (2003). A new method for closing tympanic membrane perforations using basic fibroblast growth factor. Laryngoscope 113:1352–1355
- Higashiyama S, Lau K, Besner GE, et al. (1992). Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem 267:6205–6212
- Hong P, Bance M, Gratzer PF. (2013). Repair of tympanic membrane perforation using novel adjuvant therapies: a contemporary review of experimental and tissue engineering studies. Int J Pediatr Otorhinolaryngol 77:3–12
- Kanemaru S, Umeda H, Kitani Y, et al. (2011). Regenerative treatment for tympanic membrane perforation. Otol Neurotol 32:1218–1223
- Kim DC, Sugiyama Y, Satoh H, et al. (1988). Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues. J Pharm Sci 77:200–207
- Ma Y, Zhao H, Zhou X. (2002). Topical treatment with growth factors for tympanic membrane perforations: progress towards clinical application. Acta Otolaryngol 122:586–599
- Murayama Y, Miyagawa J, Higashiyama S, et al. (1995). Localization of heparin-binding epidermal growth factor-like growth factor in human gastric mucosa. Gastroenterology 109:1051–1059
- Nakagawa T, Hayase Y, Sasahara M, et al. (1997). Distribution of heparin-binding EGF-like growth factor protein and mRNA in the normal rat kidneys. Kidney Int 51:1774–1779
- Ramalho JR, Bento RF. (2006). Healing of subacute tympanic membrane perforations in chinchillas treated with epidermal growth factor and pentoxifylline. Otol Neurotol 27:720–727
- Ronaghi M, Nasr M, Heller S. (2012). Concise review: inner ear stem cells-an oxymoron, but why? Stem Cells 30:69–74
- Ross R. (1986). The pathogenesis of atherosclerosis – an update. N Engl J Med 314:488–500
- Santa Maria PL, Oghalai JS. (2014). Is office-based myringoplasty a suitable alternative to surgical tympanoplasty? Laryngoscope 124:1053–1054
- Santa Maria PL, Redmond SL, Atlas MD, Ghassemifar R. (2010). The role of epidermal growth factor in the healing tympanic membrane following perforation in rats. J Mol Histol 41:309–314
- Santa Maria PL, Varsak KY, Kim S, Yang YP. (2015). Heparin binding-epidermal growth factor like growth factor for regeneration of chronic tympanic membrane perforations in mice. Tissue Eng A 21:1483–1494
- St Hilaire RJ, Hradek GT, Jones AL. (1983). Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high-capacity uptake system. Proc Natl Acad Sci USA 80:3797–3801
- Suzukawa K, Tomlin J, Pak K, et al. (2014). A mouse model of otitis media identifies HB-EGF as a mediator of inflammation-induced mucosal proliferation. PLoS One 9:e102739
- Yang J, Su Y, Zhou Y, Besner GE. (2014). Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: application and future prospects. Pathophysiology 21:95–104